Clinical Trials Logo

Cancer of the Brain clinical trials

View clinical trials related to Cancer of the Brain.

Filter by:
  • None
  • Page 1

NCT ID: NCT02692898 Terminated - Brain Cancer Clinical Trials

Biomarker Analysis of Central Nervous System Tumors

Start date: February 25, 2016
Phase:
Study type: Observational

Background: The number of people who get tumors of the brain or central nervous system (CNS) is lower than other cancers. But these tumors cause a higher rate of serious effects and even death. Researchers want to test existing samples of tissue from these tumors to learn more about them. This may lead to better treatment. Objective: To study stored samples of CNS tumors to learn more about the tumors and explore new ways to diagnose them. Eligibility: The study will use tissue samples already collected at NIH from people with brain or CNS tumors. Design: The participants will have given their consent in a previous study. Researchers will review the tissue samples and any data collected about them. Researchers will do lab tests and scans on the samples. All data will be kept secure.

NCT ID: NCT02334722 Completed - Brain Cancer Clinical Trials

1 Week Versus 6 Weeks of Levetiracetam in Surgical Brain Tumor Patients

Start date: August 5, 2015
Phase: Phase 4
Study type: Interventional

The purpose of this study is to see if there are any differences in patient reported neurotoxicity between patients who receive Levetiracetam tablets for one week after surgery to remove a brain tumor versus those who receive Levetiracetam tablets for six weeks after surgery. Specifically, we will see if one group has less side effects than the other, and whether or not one group has more seizures than the other.

NCT ID: NCT02193347 Completed - Brain Tumor Clinical Trials

IDH1 Peptide Vaccine for Recurrent Grade II Glioma

RESIST
Start date: January 28, 2016
Phase: Phase 1
Study type: Interventional

Potential subjects with progressive Grade II primary brain tumor that have IDH1 positive testing from the primary tumor (initial diagnosis) will be offered this treatment study in order to test the safety of the PEPIDH1M vaccine in combination with standard chemotherapy (temozolomide).

NCT ID: NCT01100658 Terminated - Brain Tumors Clinical Trials

Effects of Methylphenidate on Attention Deficits in Childhood Cancer Survivors

Start date: May 2010
Phase: N/A
Study type: Interventional

While neurocognitive impairments in attention, memory and executive functioning are commonly reported sequelae of childhood leukemia and brain tumors, studies have only recently begun to examine the treatment of attention deficits in this population. Numerous studies have examined the effectiveness of methylphenidate in the treatment of children with attention deficit hyperactivity disorder (ADHD). However, the effectiveness of this medication for improving attention and behavioral functioning in children with medical illnesses or brain injury are less clear. Patients will be randomized to receive one week of Metadate CD (a controlled release form of methylphenidate, similar to Ritalin) and one week of placebo in a double-blind fashion.